Nephros, Inc.
NEPH
$1.89
-$0.08-4.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 10.01% | 8.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.01% | 8.18% | |||
| Cost of Revenue | 1.90% | 2.16% | |||
| Gross Profit | 15.17% | 12.40% | |||
| SG&A Expenses | 8.77% | -11.33% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.28% | -7.20% | |||
| Operating Income | 53.88% | 164.98% | |||
| Income Before Tax | 98.91% | 163.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 90.71% | 163.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 90.71% | 163.32% | |||
| EBIT | 53.88% | 164.98% | |||
| EBITDA | 47.28% | 184.75% | |||
| EPS Basic | 90.23% | 163.27% | |||
| Normalized Basic EPS | 100.00% | 162.79% | |||
| EPS Diluted | 90.23% | 163.27% | |||
| Normalized Diluted EPS | 100.00% | 162.79% | |||
| Average Basic Shares Outstanding | 0.00% | 0.33% | |||
| Average Diluted Shares Outstanding | -0.24% | 0.68% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||